HTML from...
URL: https://open.canada.ca/data/en/dataset/f5ba4df7-f285-42e8-9519-cedbe71cb5f7
Health Canada reviewed the potential risk of DRESS with the use of atypical antipsychotics, following the manufacturers’ voluntary update of the product safety information for Zyprexa (olanzapine) and Zeldox (ziprasidone) to include the risk of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). DRESS describes a group of rare but serious and potentially life-threatening side effects to medications, such as fever, severe skin rash with swollen face or peeling of the skin over large areas of the body, etc.
Il n'y a encore aucune visualisation créée pour cette ressource
Informations additionnelles
| Champ | Valeur |
|---|---|
| Dernière modification de la donnée | 16 janvier 2026 |
| Dernière modification de la métadonnée | 16 janvier 2026 |
| Créé le | 16 janvier 2026 |
| Format | HTML |
| Licence | License not specified |
| Datastore active | False |
| Has views | False |
| Id | 9c2e6ec7-5b6b-4587-85db-fe6e6247e01e |
| Package id | a201795b-9664-4d87-8875-9d8fb7feae31 |
| Position | 0 |
| State | active |